The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Hemostasis Diagnostics-Global Market Insights and Sales Trends 2024

Hemostasis Diagnostics-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1860326

No of Pages : 87

Ask Your Query

Synopsis

Hemophilia, vitamin k deficiency, and disseminated intravascular coagulation are some of the factors responsible for blood clotting disorders that not only requires relevant treatment, but also timely and affordable diagnosis.

The global Hemostasis Diagnostics market size is expected to reach US$ 796.5 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Hemostasis Diagnostics in various end use industries. The expanding demands from the Hospitals, Diagnostic Centers and Others,, are propelling Hemostasis Diagnostics market. Laboratory Analyzers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Point-of-Care Testing Systems segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hemostasis Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Hemostasis Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Hemostasis Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hemostasis Diagnostics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Hemostasis Diagnostics covered in this report include Abbott, Thermo Fisher Scientific, Roche, Nihon Kohden, Sysmex, Siemens Healthineers, Instrumentation Laboratory, Beckman Coulter and Grifols, etc.

The global Hemostasis Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Abbott
  • Thermo Fisher Scientific
  • Roche
  • Nihon Kohden
  • Sysmex
  • Siemens Healthineers
  • Instrumentation Laboratory
  • Beckman Coulter
  • Grifols

Global Hemostasis Diagnostics market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Hemostasis Diagnostics market, Segment by Type:

  • Laboratory Analyzers
  • Point-of-Care Testing Systems

Global Hemostasis Diagnostics market, by Application:

  • Hospitals
  • Diagnostic Centers
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hemostasis Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Hemostasis Diagnostics
1.1 Hemostasis Diagnostics Market Overview
1.1.1 Hemostasis Diagnostics Product Scope
1.1.2 Hemostasis Diagnostics Market Status and Outlook
1.2 Global Hemostasis Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hemostasis Diagnostics Market Size by Region (2018-2029)
1.4 Global Hemostasis Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Hemostasis Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hemostasis Diagnostics Market Size (2018-2029)
1.6.1 North America Hemostasis Diagnostics Market Size (2018-2029)
1.6.2 Europe Hemostasis Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Hemostasis Diagnostics Market Size (2018-2029)
1.6.4 Latin America Hemostasis Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Hemostasis Diagnostics Market Size (2018-2029)
2 Hemostasis Diagnostics Market by Type
2.1 Introduction
2.1.1 Laboratory Analyzers
2.1.2 Point-of-Care Testing Systems
2.2 Global Hemostasis Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hemostasis Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Hemostasis Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hemostasis Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hemostasis Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hemostasis Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hemostasis Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hemostasis Diagnostics Revenue Breakdown by Type (2018-2029)
3 Hemostasis Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Diagnostic Centers
3.1.3 Others
3.2 Global Hemostasis Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hemostasis Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Hemostasis Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hemostasis Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hemostasis Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hemostasis Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hemostasis Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hemostasis Diagnostics Revenue Breakdown by Application (2018-2029)
4 Hemostasis Diagnostics Competition Analysis by Players
4.1 Global Hemostasis Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemostasis Diagnostics as of 2022)
4.3 Date of Key Players Enter into Hemostasis Diagnostics Market
4.4 Global Top Players Hemostasis Diagnostics Headquarters and Area Served
4.5 Key Players Hemostasis Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Hemostasis Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Hemostasis Diagnostics Products, Services and Solutions
5.1.4 Abbott Hemostasis Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Hemostasis Diagnostics Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Hemostasis Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Hemostasis Diagnostics Products, Services and Solutions
5.3.4 Roche Hemostasis Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Nihon Kohden Recent Developments
5.4 Nihon Kohden
5.4.1 Nihon Kohden Profile
5.4.2 Nihon Kohden Main Business
5.4.3 Nihon Kohden Hemostasis Diagnostics Products, Services and Solutions
5.4.4 Nihon Kohden Hemostasis Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Nihon Kohden Recent Developments
5.5 Sysmex
5.5.1 Sysmex Profile
5.5.2 Sysmex Main Business
5.5.3 Sysmex Hemostasis Diagnostics Products, Services and Solutions
5.5.4 Sysmex Hemostasis Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Sysmex Recent Developments
5.6 Siemens Healthineers
5.6.1 Siemens Healthineers Profile
5.6.2 Siemens Healthineers Main Business
5.6.3 Siemens Healthineers Hemostasis Diagnostics Products, Services and Solutions
5.6.4 Siemens Healthineers Hemostasis Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Siemens Healthineers Recent Developments
5.7 Instrumentation Laboratory
5.7.1 Instrumentation Laboratory Profile
5.7.2 Instrumentation Laboratory Main Business
5.7.3 Instrumentation Laboratory Hemostasis Diagnostics Products, Services and Solutions
5.7.4 Instrumentation Laboratory Hemostasis Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Instrumentation Laboratory Recent Developments
5.8 Beckman Coulter
5.8.1 Beckman Coulter Profile
5.8.2 Beckman Coulter Main Business
5.8.3 Beckman Coulter Hemostasis Diagnostics Products, Services and Solutions
5.8.4 Beckman Coulter Hemostasis Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Beckman Coulter Recent Developments
5.9 Grifols
5.9.1 Grifols Profile
5.9.2 Grifols Main Business
5.9.3 Grifols Hemostasis Diagnostics Products, Services and Solutions
5.9.4 Grifols Hemostasis Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Grifols Recent Developments
6 North America
6.1 North America Hemostasis Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hemostasis Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hemostasis Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hemostasis Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hemostasis Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hemostasis Diagnostics Market Dynamics
11.1 Hemostasis Diagnostics Industry Trends
11.2 Hemostasis Diagnostics Market Drivers
11.3 Hemostasis Diagnostics Market Challenges
11.4 Hemostasis Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock